Brent Korte

Health Economics & Reimbursement Lead Canada


Novateur Advisor Since



Health Economics & Reimbursement


Market Assessment & Reimbursement, Devices, Diagnostics, Drug & Device Combination, Therapeutics, CNS, Dermatology, Immunology, Oncology & Immuno-Oncology, Ophthalmology, COVID-19

"Enabling and facilitating access to novel, innovative therapies and innovations is a passion of mine that allows me to work efficiently in a collaborative team environment and offer significant value to innovators."

Brent Korte
Health Economics & Reimbursement Lead Canada

Brent Korte has 25 years of pharmaceutical experience in reimbursement strategy, market access, and sales. He has also managed the national market access team, with responsibility for public, private, and federal plans in all jurisdictions across Canada. He was responsible for strategy and action plan development, as well as community/advocacy relations, building strong relationships with regional and national coalition partners. As part of the strategy and action plan development, Brent led the development of the policy agenda in partnership with the leadership team, presenting the overall agenda and messages to the team and appropriate business partners. Specific policy issues identified and led included pCPA, National Pharmacare, Subsequent Entry Biologics, lifecycle management, substance abuse and diversion, and orphan drug strategy and real world evidence (RWE) development. For the last 22 years, Brent has been working with Janssen Pharmaceutical Companies of Johnson & Johnson. He currently leads Novateur’s Reimbursement Strategy Unit for Canada.

Novateur Newsletter

Subscribe to our newsletter for access to latest updates.

Resource Databases

Access Novateur news as well as FDA and Expert Databases.

Relevant Events

Check out conferences and events we are attending!